Recent studies have shown that the overexpression of MAP4K1 is associated with poor prognosis in AML, as it enhances drug resistance by regulating the MAPK pathway through Jun and JNK signaling factors23,24. Here, MAPK8 is linked to acute myeloid leukemia.